Preprint · OA
via OpenAlex
Alpha-Synuclein Pathology and Axonal Degeneration of the Peripheral Motor Nerves Innervating Pharyngeal Muscles in Parkinson Disease
Liancai Mu, Stanisław Sobótka, Jingming Chen, Hungxi Su, Ira Sanders, Charles H. Adler, Holly A. Shill, John N. Caviness, Johan Samanta, Thomas G. Beach
Journal of Neuropathology & Experimental Neurology · 2013 · ▲ 153 citations
Abstract
Parkinson disease (PD) is a neurodegenerative disease primarily characterized by cardinal motor manifestations and CNS pathology. Current drug therapies can often stabilize these cardinal motor symptoms, and attention has shifted to the other motor and nonmotor symptoms of PD that are resistant to drug therapy. Dysphagia in PD is perhaps the most important drug-resistant symptom because it leads to aspiration and pneumonia, the leading cause of death. Here, we present direct evidence for degeneration of the pharyngeal motor nerves in PD. We examined the cervical vagal nerve (cranial nerve X), pharyngeal branch of nerve X, and pharyngeal plexus innervating the pharyngeal muscles in 14 postmortem specimens, that is, from 10 patients with PD and 4 age-matched control subjects. Synucleinopathy in the pharyngeal nerves was detected using an immunohistochemical method for phosphorylated α-synuclein. Alpha-synuclein aggregates were revealed in nerve X and the pharyngeal branch of nerve X, and immunoreactive intramuscular nerve twigs and axon terminals within the neuromuscular junctions were identified in all of the PD patients but in none of the controls. These findings indicate that the motor nervous system of the pharynx is involved in the pathologic process of PD. Notably, PD patients who have had dysphagia had a higher density of α-synuclein aggregates in the pharyngeal nerves than those without dysphagia. These findings indicate that motor involvement of the pharynx in PD is one of the factors leading to oropharyngeal dysphagia commonly seen in PD patients.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1097/nen.0b013e3182801cde
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Mu, L., Sobótka, S., Chen, J., Su, H., Sanders, I., Adler, C.H., Shill, H.A., Caviness, J.N., Samanta, J., & Beach, T.G. (2013). Alpha-Synuclein Pathology and Axonal Degeneration of the Peripheral Motor Nerves Innervating Pharyngeal Muscles in Parkinson Disease. <em>Journal of Neuropathology & Experimental Neurology</em>. https://doi.org/10.1097/nen.0b013e3182801cde
Vancouver
Mu L, Sobótka S, Chen J, Su H, Sanders I, Adler CH, et al. Alpha-Synuclein Pathology and Axonal Degeneration of the Peripheral Motor Nerves Innervating Pharyngeal Muscles in Parkinson Disease. Journal of Neuropathology & Experimental Neurology. 2013. doi:10.1097/nen.0b013e3182801cde.
BibTeX
@unpublished{liancai2013AlphaS,
title = {Alpha-Synuclein Pathology and Axonal Degeneration of the Peripheral Motor Nerves Innervating Pharyngeal Muscles in Parkinson Disease},
author = {Liancai Mu and Stanisław Sobótka and Jingming Chen and Hungxi Su and Ira Sanders and Charles H. Adler and Holly A. Shill and John N. Caviness and Johan Samanta and Thomas G. Beach},
journal = {Journal of Neuropathology & Experimental Neurology},
year = {2013},
doi = {10.1097/nen.0b013e3182801cde},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Scientific Reports 2017
Open access · CC-BY
Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson’s disease
Movement Disorders 2018
Open access · CC-BY
Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells
Neural Plasticity 2017
Open access · CC-BY
The Contribution of α -Synuclein Spreading to Parkinson’s Disease Synaptopathy
Journal of Neurochemistry 2010
Open access · OA
Nature and cause of mitochondrial dysfunction in Huntington’s disease: focusing on huntingtin and the striatum
bioRxiv (Cold Spring Harbor Laboratory) 2019
Preprint · OA
Alpha-synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s disease
University Hospital, Strasbourg, France 2010
Open access · US-GOV